CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 09/30/2014

Position Statistics

Total Positions 68
New Positions 16
Increased Positions 24
Decreased Positions 13
Positions with Activity 37
Sold Out Positions 4
Total Mkt Value (in $ millions) 633

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 14.94%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 62.42%
Services
Technology
Transportation
Utilities

68 Positions as of 09/30/2014

Company ▲ Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held
ACADIA PHARMACEUTICALS COM -1,553 Sold Out 0
ACCELERON PHARMA INC COM 15,724 7,862 100 400,000
ACELRX PHARMACEUTICALS INC COM 6,920 2,076 42.86 1,000,000
ADVAXIS INC COM NEW 3,549 3,549 New 350,000
AGENUS INC COM NEW 3,393 -1,305 (27.78) 650,000
AGILE THERAPEUTICS INC COM 1,275 New 150,000
AGIOS PHARMACEUTICALS INC COM 12,073 12,073 New 100,000
AKEBIA THERAPEUTICS INC COM 4,332 New 400,000
ALDER BIOPHARMACEUTICALS INC COM 4,037 New 150,000
ALKERMES PLC SHS 7,219 New 100,000
ALNYLAM PHARMACEUTICALS INC COM 4,672 New 50,000
APPLIED GENETIC TECHNOL CORP COM 1,492 -3,890 (72.28) 60,600
AQUINOX PHARMACEUTICALS INC COM 3,225 New 300,000
ARDELYX INC COM 10,639 10,639 New 388,700
ARRAY BIOPHARMA INC COM 7,460 New 1,000,000
ARROWHEAD RESH CORP COM NEW 5,940 New 900,000
AUSPEX PHARMACEUTICALS INC COM 6,095 New 100,000
AVALANCHE BIOTECHNOLOGIES INC COM 2,567 2,567 New 65,000
BIOCRYST PHARMACEUTICALS COM 11,748 -726 (5.82) 1,100,000
BRISTOL MYERS SQUIBB CO COM 9,171 9,171 New 150,000